GR3022103T3 - Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension. - Google Patents
Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension.Info
- Publication number
- GR3022103T3 GR3022103T3 GR960403151T GR960403151T GR3022103T3 GR 3022103 T3 GR3022103 T3 GR 3022103T3 GR 960403151 T GR960403151 T GR 960403151T GR 960403151 T GR960403151 T GR 960403151T GR 3022103 T3 GR3022103 T3 GR 3022103T3
- Authority
- GR
- Greece
- Prior art keywords
- imidazolyl
- benzimidazolyl
- hypertension
- treatment
- alanine amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/930,076 US5373017A (en) | 1992-08-14 | 1992-08-14 | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
PCT/US1993/007511 WO1994004508A1 (en) | 1992-08-14 | 1993-08-13 | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3022103T3 true GR3022103T3 (en) | 1997-03-31 |
Family
ID=25458896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960403151T GR3022103T3 (en) | 1992-08-14 | 1996-12-19 | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension. |
Country Status (11)
Country | Link |
---|---|
US (3) | US5373017A (el) |
EP (1) | EP0655059B1 (el) |
JP (1) | JPH08500118A (el) |
AT (1) | ATE146460T1 (el) |
AU (1) | AU669005B2 (el) |
CA (1) | CA2136838A1 (el) |
DE (1) | DE69306794T2 (el) |
DK (1) | DK0655059T3 (el) |
ES (1) | ES2095749T3 (el) |
GR (1) | GR3022103T3 (el) |
WO (1) | WO1994004508A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5373017A (en) * | 1992-08-14 | 1994-12-13 | G. D. Searle & Co. | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
US20020115867A1 (en) * | 1992-08-14 | 2002-08-22 | Hanson Gunnar J. | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
US5508466A (en) * | 1994-04-13 | 1996-04-16 | G.D. Searle & Co. | Synthesis of N-protected-α-substituted-glycine racemic esters by zinc-mediated addition of organic halide to glycine cation equivalent |
US7355068B2 (en) * | 2006-01-04 | 2008-04-08 | Eastman Chemical Company | Oxidation system with internal secondary reactor |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769271A (en) * | 1971-04-15 | 1973-10-30 | Lilly Co Eli | N-protected amino acids and peptides |
JPS59227851A (ja) * | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
EP0181110A3 (en) * | 1984-10-22 | 1988-05-11 | Kissei Pharmaceutical Co. Ltd. | Histidine derivatives as renin inhibitors |
SU1676454A3 (ru) * | 1984-11-30 | 1991-09-07 | Санкио Компани Лимитед (Фирма) | Способ получени пептидов или их фармацевтически приемлемых солей |
DK34086A (da) * | 1985-01-23 | 1986-07-24 | Abbott Lab | Peptidylaminodioler |
JPS61236770A (ja) * | 1985-04-15 | 1986-10-22 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
JPS6256458A (ja) * | 1985-09-04 | 1987-03-12 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
IL81234A (en) * | 1986-01-16 | 1992-09-06 | Abbott Lab | Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them |
JPS63503380A (ja) * | 1986-01-16 | 1988-12-08 | アボット・ラボラトリーズ | ペプチド類似体 |
US5032577A (en) * | 1986-12-31 | 1991-07-16 | Abbott Laboratories | Peptidylaminodiols |
US4921855A (en) * | 1987-06-22 | 1990-05-01 | Fujisawa Pharmaceutical Co., Ltd. | New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same |
US5036051A (en) * | 1987-10-06 | 1991-07-30 | Abbott Laboratories | Glaucoma treatment |
US5036053A (en) * | 1988-05-27 | 1991-07-30 | Warner-Lambert Company | Diol-containing renin inhibitors |
US4902706A (en) * | 1988-07-01 | 1990-02-20 | G. D. Searle & Co. | Aminoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents |
IE902446A1 (en) * | 1989-07-26 | 1991-02-13 | Abbott Lab | Peptidyl aminodiol renin inhibitors |
US5175181A (en) * | 1989-12-04 | 1992-12-29 | G. D. Searle & Co. | Imidazolyl/imidazolylalkyl-N-terminal amino hydroxy |
IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
EP0539976A1 (en) * | 1991-10-29 | 1993-05-05 | G.D. Searle & Co. | Ethynyl-alanine-amino-diol compounds for treatment of hypertension |
US5373017A (en) * | 1992-08-14 | 1994-12-13 | G. D. Searle & Co. | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
-
1992
- 1992-08-14 US US07/930,076 patent/US5373017A/en not_active Expired - Fee Related
-
1993
- 1993-08-13 WO PCT/US1993/007511 patent/WO1994004508A1/en active IP Right Grant
- 1993-08-13 ES ES94908098T patent/ES2095749T3/es not_active Expired - Lifetime
- 1993-08-13 AT AT94908098T patent/ATE146460T1/de not_active IP Right Cessation
- 1993-08-13 JP JP6506361A patent/JPH08500118A/ja not_active Ceased
- 1993-08-13 CA CA002136838A patent/CA2136838A1/en not_active Abandoned
- 1993-08-13 EP EP94908098A patent/EP0655059B1/en not_active Expired - Lifetime
- 1993-08-13 AU AU50037/93A patent/AU669005B2/en not_active Ceased
- 1993-08-13 DE DE69306794T patent/DE69306794T2/de not_active Expired - Fee Related
- 1993-08-13 DK DK94908098.0T patent/DK0655059T3/da active
-
1996
- 1996-12-19 GR GR960403151T patent/GR3022103T3/el unknown
-
2002
- 2002-11-08 US US10/290,944 patent/US20030130329A1/en not_active Abandoned
-
2003
- 2003-08-12 US US10/639,394 patent/US20040087801A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU5003793A (en) | 1994-03-15 |
JPH08500118A (ja) | 1996-01-09 |
US5373017A (en) | 1994-12-13 |
ATE146460T1 (de) | 1997-01-15 |
DE69306794T2 (de) | 1997-05-07 |
US20030130329A1 (en) | 2003-07-10 |
EP0655059B1 (en) | 1996-12-18 |
DK0655059T3 (da) | 1997-01-06 |
DE69306794D1 (de) | 1997-01-30 |
US20040087801A1 (en) | 2004-05-06 |
AU669005B2 (en) | 1996-05-23 |
ES2095749T3 (es) | 1997-02-16 |
CA2136838A1 (en) | 1994-03-03 |
WO1994004508A1 (en) | 1994-03-03 |
EP0655059A1 (en) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2256582A1 (en) | Oxa acids and related compounds for treating skin conditions | |
DK0948527T3 (da) | Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse | |
ES8600312A1 (es) | Un procedimiento para preparacion de nuevos derivados de cefalosporina. | |
AU3725393A (en) | Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension | |
GR3025521T3 (en) | Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors. | |
GR3022103T3 (en) | Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension. | |
HUP9902465A1 (hu) | Új amidínium-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
GR3031861T3 (en) | Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension. | |
DK0628042T3 (da) | Serotoninerge ergolinderivater | |
CA2144344A1 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents | |
AU4999493A (en) | Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension | |
CA2244402A1 (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents | |
ES2052535T3 (es) | Sintesis de amino-alquil-amidas de peptidos o hidrazidas de peptidos mediante un metodo en fase solida. | |
ATE139444T1 (de) | Carbocyklische nukleosidanaloge als immunsuppressoren | |
FI934016A (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva kinolin- eller naftyridinkarboxylsyraderivat som innehaoller en spirosubstituent |